Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 21 results.
User Information
Export Records
  1. 1.   Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
  2. Zhou, Tongqing; Teng, I-Ting; Olia, Adam S; Cerutti, Gabriele; Gorman, Jason; Nazzari, Alexandra; Shi, Wei; Tsybovsky,Yaroslav; Wang, Lingshu; Wang, Shuishu; Zhang, Baoshan; Zhang, Yi; Katsamba, Phinikoula S; Petrova, Yuliya; Banach, Bailey B; Fahad, Ahmed S; Liu, Lihong; Lopez Acevedo, Sheila N; Madan, Bharat; Oliveira de Souza, Matheus; Pan, Xiaoli; Wang, Pengfei; Wolfe, Jacy R; Yin, Michael; Ho, David D; Phung, Emily; DiPiazza, Anthony; Chang, Lauren A; Abiona, Olubukola M; Corbett, Kizzmekia S; DeKosky, Brandon J; Graham, Barney S; Mascola, John R; Misasi, John; Ruckwardt, Tracy; Sullivan, Nancy J; Shapiro, Lawrence; Kwong, Peter D
  3. Cell reports. 2020, Oct 27; 33(4): 108322.
  1. 2.   Activation mechanism of plasmepsins, pepsin-like aspartic proteases from Plasmodium, follows a unique trans-activation pathway
  2. Rathore, Ishan; Mishra, Vandana; Patel, Chandan; Xiao, Huogen; Gustchina,Alla; Wlodawer,Alexander; Yada, Rickey Y; Bhaumik, Prasenjit
  3. The FEBS journal. 2020, MAY 26;
  1. 3.   Structural studies of vacuolar plasmepsins
  2. Bhaumik, P.; Gustchina, A.; Wlodawer, A.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2012, Jan; 1824(1): 207-223.
  1. 4.   An overview of enzymatic reagents for the removal of affinity tags
  2. Waugh, D. S.
  3. Protein Expression and Purification. 2011, Dec; 80(2): 283-293.
  1. 5.   Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease
  2. Li, M.; Gustchina, A.; Matuz, K.; Tozser, J.; Namwong, S.; Goldfarb, N. E.; Dunn, B. M.; Wlodawer, A.
  3. Febs Journal. 2011, Nov; 278(22): 4413-4424.
  1. 6.   Structural Insights into the Activation and Inhibition of Histo-Aspartic Protease from Plasmodium falciparum
  2. Bhaumik, P.; Xiao, H. G.; Hidaka, K.; Gustchina, A.; Kiso, Y.; Yada, R. Y.; Wlodawer, A.
  3. Biochemistry. 2011, Oct; 50(41): 8862-8879.
  1. 7.   Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum
  2. Bhaumik, P.; Horimoto, Y.; Xiao, H. G.; Miura, T.; Hidaka, K.; Kiso, Y.; Wlodawer, A.; Yada, R. Y.; Gustchina, A.
  3. Journal of Structural Biology. 2011, Jul; 175(1): 73-84.
  1. 8.   A set of aspartyl protease-deficient strains for improved expression of heterologous proteins in Kluyveromyces lactis
  2. Ganatra, M. B.; Vainauskas, S.; Hong, J. M.; Taylor, T. E.; Denson, J. P. M.; Esposito, D.; Read, J. D.; Schmeisser, H.; Zoon, K. C.; Hartley, J. L.; Taron, C. H.
  3. Fems Yeast Research. 2011, Mar; 11(2): 168-178.
  1. 9.   Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes
  2. Robbins, A. H.; Coman, R. M.; Bracho-Sanchez, E.; Fernandez, M. A.; Gilliland, C. T.; Li, M.; Agbandje-McKenna, M.; Wlodawer, A.; Dunn, B. M.; McKenna, R.
  3. Acta Crystallographica Section D-Biological Crystallography. 2010, Mar; 66: 233-242.
  1. 10.   Impact of pro segments on the folding and function of human neutrophil alpha-defensins
  2. Wu, Z. B.; Li, X. Q.; Ericksen, B.; de Leeuw, E.; Zou, G. Z.; Zeng, P. Y.; Xie, C.; Li, C.; Lubkowski, J.; Lu, W. Y.; Lu, W. Y.
  3. Journal of Molecular Biology. 2007, Apr; 368(2): 537-549.
  1. 11.   Crystal structure of cockroach allergen Bla g 2, an unusual zinc binding aspartic protease with a novel mode of self-inhibition
  2. Gustchina, A.; Li, M.; Wunschmann, S.; Chapman, M. D.; Pomes, A.; Wlodawer, A.
  3. Journal of Molecular Biology. 2005, APR 29; 348(2): 433-444.
  1. 12.   Kinetic stability and crystal structure of the viral capsid protein SHP
  2. Forrer, P.; Chang, C. S.; Ott, D.; Wlodawer, A.; Pluckthun, A.
  3. Journal of Molecular Biology. 2004, NOV 12; 344(1): 179-193.
  1. 13.   Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum
  2. Asojo, O. A.; Gulnik, S. V.; Afonina, E.; Yu, B.; Ellman, J. A.; Haque, T. S.; Silva, A. M.
  3. Journal of Molecular Biology. 2003 327(1): 173-181.
  1. 14.   Structural basis for the substrate specificity of tobacco etch virus protease
  2. Phan, J.; Zdanov, A.; Evdokimov, A. G.; Tropea, J. E.; Peters, H. K.; Kapust, R. B.; Li, M.; Wlodawer, A.; Waugh, D. S.
  3. Journal of Biological Chemistry. 2002 277(52): 50564-50572.
  1. 15.   Protein folding: Binding of conformationally fluctuating building blocks via population selection
  2. Tsai, C. J.; Ma, B. Y.; Kumar, S.; Wolfson, H.; Nussinov, R.
  3. Critical Reviews in Biochemistry and Molecular Biology. 2001 36(5): 399-433.
  1. 16.   Binding and folding: in search of intramolecular chaperone-like building block fragments
  2. Ma, B. Y.; Tsai, C. J.; Nussinov, R.
  3. Protein Engineering. 2000 13(9): 617-627.
  1. 17.   Structural and biochemical studies of retroviral proteases
  2. Wlodawer, A.; Gustchina, A.
  3. Biochimica et Biophysica Acta - Protein Structure & Molecular Enzymology. 2000 1477(1-2): 16-34.
  1. 18.   Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: A lead HIV protease inhibitor
  2. Prasad, J.; Boyer, F. E.; Domagala, J. M.; Ellsworth, E. L.; Gajda, C.; Hamilton, H. W.; Hagen, S. E.; Markoski, L. J.; Steinbaugh, B. A.; Tait, B. D.; Humblet, C.; Lunney, E. A.; Pavlovsky, A.; Rubin, J. R.; Ferguson, D.; Graham, N.; Holler, T.; Hupe, D.; Nouhan, C.; Tummino, P. J.; Urumov, A.; Zeikus, E.; Zeikus, G.; Gracheck, S. J.; Saunders, J. M.
  3. Bioorganic & Medicinal Chemistry. 1999 7(12): 2775-2800.
  1. 19.   Drug-Resistant Hiv-1 Proteases Identify Enzyme Residues Important For Substrate Selection and Catalytic Rate
  2. Ridky, T. W.; Kikonyogo, A.; Leis, J.
  3. Biochemistry. 1998 37(39): 13835-13845.
  1. 20.   Analysis of the Structure of Hiv-1 Protease Complexed With a Hexapeptide Inhibitor .2. Molecular Dynamic Studies of the Active Site Region
  2. Geller, M.; Miller, M.; Swanson, S. M.; Maizel, J.
  3. Proteins. 1997 27(2): 195-203.
  1. 21.   Analysis of the Structure of Chemically Synthesized Hiv-1 Protease Complexed With a Hexapeptide Inhibitor .1. Crystallographic Refinement of 2 Angstrom Data
  2. Miller, M.; Geller, M.; Gribskov, M.; Kent, S. B. H.
  3. Proteins. 1997 27(2): 184-194.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel